Atantares develops molecular chips that use integrated circuits and semiconductor technologies to drive biotechnology applications. Its first application is high-throughput DNA synthesis, aiming to reduce the cost of DNA synthesis using CMOS chip-based gene synthesis. The company says its first-generation short-chain CMOS chips have been taped out. It has also strategically pursued an enzymatic biological method as a complementary path and is developing controllable strategies to improve enzyme efficiency and automation for enzymatic synthesis. Atantares intends to use recently raised funds for R&D, service operations, and capacity expansion. The company was founded in 2021 and is pursuing both semiconductor and enzymatic approaches in parallel.

Total raised

$28M

Funding rounds

2

Latest round

Series A

Latest activity

Aug 2023